Dupilumab Safety in Patients with Long-Term Moderate-to-Severe Asthma
The following is a summary of "Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study," published in the April 2024 issue of Allergy & Immunology by Maspero, et al. Previous clinical trials have demonstrated the...